![Keld Søndergaard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Keld Søndergaard worked as a Director at Xintela AB in 2017 and as the Chief Financial Officer at AFYX Therapeutics AS.
Eerdere bekende functies van Keld Søndergaard
Bedrijven | Functie | Einde |
---|---|---|
XINTELA AB | Directeur/Bestuurslid | 17-10-2017 |
AFYX Therapeutics AS
![]() AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
XINTELA AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
AFYX Therapeutics AS
![]() AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Commercial Services |